71 related articles for article (PubMed ID: 31907980)
1. MEK2 is a critical modulating mechanism to down-regulate GCIP stability and function in cancer cells.
Liang RY; Liu BH; Huang CJ; Lin KT; Ko CC; Huang LL; Hsu B; Wu CY; Chuang SM
FASEB J; 2020 Feb; 34(2):1958-1969. PubMed ID: 31907980
[TBL] [Abstract][Full Text] [Related]
2. GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion.
Chen KY; Chen CC; Tseng YL; Chang YC; Chang MC
Oncotarget; 2014 Jul; 5(13):5017-28. PubMed ID: 24970809
[TBL] [Abstract][Full Text] [Related]
3. A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment.
Lee I; Yeom SY; Lee SJ; Kang WK; Park C
Cancer Res; 2010 Jun; 70(11):4357-65. PubMed ID: 20460530
[TBL] [Abstract][Full Text] [Related]
4. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.
Ma W; Stafford LJ; Li D; Luo J; Li X; Ning G; Liu M
J Cell Biochem; 2007 Apr; 100(6):1376-86. PubMed ID: 17131381
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells.
Chang TW; Chen CC; Chen KY; Su JH; Chang JH; Chang MC
Oncogene; 2008 Jan; 27(3):332-8. PubMed ID: 17621266
[TBL] [Abstract][Full Text] [Related]
6. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
Hong SK; Wu PK; Karkhanis M; Park JI
Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
[TBL] [Abstract][Full Text] [Related]
7. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.
Yu C; Zhang Z; Liao W; Zhao X; Liu L; Wu Y; Liu Z; Li Y; Zhong Y; Chen K; Li J; Zhou F; Song L
Carcinogenesis; 2012 Mar; 33(3):678-86. PubMed ID: 22223847
[TBL] [Abstract][Full Text] [Related]
8. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.
Ma W; Xia X; Stafford LJ; Yu C; Wang F; LeSage G; Liu M
Oncogene; 2006 Jul; 25(30):4207-16. PubMed ID: 16501603
[TBL] [Abstract][Full Text] [Related]
9. miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor.
Zhu SW; Li JP; Ma XL; Ma JX; Yang Y; Chen Y; Liu W
Asian Pac J Cancer Prev; 2015; 16(11):4509-13. PubMed ID: 26107195
[TBL] [Abstract][Full Text] [Related]
10. The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.
Li W; Cui K; Prochownik EV; Li Y
Cell Death Dis; 2018 May; 9(5):482. PubMed ID: 29706623
[TBL] [Abstract][Full Text] [Related]
11. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
13. p29, a novel GCIP-interacting protein, localizes in the nucleus.
Chang MS; Chang CL; Huang CJ; Yang YC
Biochem Biophys Res Commun; 2000 Dec; 279(2):732-7. PubMed ID: 11118353
[TBL] [Abstract][Full Text] [Related]
14. LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.
Zhang Y; Zhang Y; Xu H
Gene; 2019 Sep; 712():143963. PubMed ID: 31279706
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway.
Zeng Z; Gao ZL; Zhang ZP; Jiang HB; Yang CQ; Yang J; Xia XB
Int J Mol Med; 2019 Jul; 44(1):103-114. PubMed ID: 31115482
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of GCIP in breast carcinoma: relationship with tumour grade, disease-free survival, mucinous differentiation and response to chemotherapy.
Chen WC; Su PF; Jin YT; Chang MC; Chang TW
Histopathology; 2008 Nov; 53(5):554-60. PubMed ID: 18983464
[TBL] [Abstract][Full Text] [Related]
17. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
Roy M; Li Z; Sacks DB
Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
19. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.
Bhatt KV; Spofford LS; Aram G; McMullen M; Pumiglia K; Aplin AE
Oncogene; 2005 May; 24(21):3459-71. PubMed ID: 15735667
[TBL] [Abstract][Full Text] [Related]
20. MEK1 and MEK2 differentially regulate human insulin- and insulin glargine-induced human bladder cancer T24 cell proliferation.
Liu SY; Liang Y; Lin TX; Su F; Liang WW; Uwe H; Li Y
Chin Med J (Engl); 2012 Dec; 125(23):4197-201. PubMed ID: 23217386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
